Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/stuart-therapeutics-announces-first-patient-first-visit-in-its-phase-3-clinical-trial-of-vezocolmitide-for-dry-eye-disease-302023987.html
https://www.prnewswire.com/news-releases/stuart-therapeutics-announces-exclusive-worldwide-license-agreement-with-glaukos-corporation-301961150.html
https://www.prnewswire.com/news-releases/stuart-therapeutics-announces-issuance-of-us-patent-covering-ophthalmic-anterior-segment-disorders-301922051.html
https://www.prnewswire.com/news-releases/stuart-therapeutics-inc-announces-expansion-of-its-development-pipeline-additions-to-its-scientific-advisory-board-301715886.html
https://www.prnewswire.com/news-releases/stuart-therapeutics-inc-announces-licensing-agreement-with-aju-pharm-co-ltd-301712587.html
https://www.prnewswire.com/news-releases/stuart-therapeutics-announces-important-additions-to-the-companys-intellectual-property-portfolio-301591971.html
https://www.prnewswire.com/news-releases/stuart-therapeutics-announces-successful-outcome-from-type-c-meeting-with-fda-301588184.html
https://www.biospace.com/article/releases/stuart-therapeutics-inc-announces-successful-phase-2-clinical-trial-results-of-its-novel-dry-eye-candidate-st-100/